Increased Staphylococcus aureus Nasal Carriage Rates in Rheumatoid Arthritis Patients on Biologic Therapy
- 1 May 2019
- journal article
- research article
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 34 (5) , 954-958
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Clinical Isolates in the United States, 2004 to 2010Journal of Clinical Microbiology, 2013
- Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2013
- Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics RegisterAnnals of the Rheumatic Diseases, 2011
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriersCochrane Database of Systematic Reviews, 2008
- Changes in the Prevalence of Nasal Colonization withStaphylococcus aureusin the United States, 2001–2004The Journal of Infectious Diseases, 2008
- Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database ManagementJournal of Clinical Microbiology, 2003
- Frequency of infection in patients with rheumatoid arthritis compared with controls: A population‐based studyArthritis & Rheumatism, 2002
- Nasal Carriage as a Source ofStaphylococcus aureusBacteremiaNew England Journal of Medicine, 2001
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988